How much funding has Scorpion Therapeutics raised?

Scorpion Therapeutics has raised $420.0M in total funding, most recently a Series C round.

Who are Scorpion Therapeutics's investors?

Scorpion Therapeutics's investors include Atlas Venture, Vida Ventures, Frazier Life Sciences, Lightspeed VP, Abingworth Bioventures, Invus.

When was Scorpion Therapeutics founded?

Scorpion Therapeutics was founded in 2020.

Where is Scorpion Therapeutics headquartered?

Scorpion Therapeutics is headquartered in Boston, Massachusetts, United States.

What industry is Scorpion Therapeutics in?

Scorpion Therapeutics operates in Biotech, Healthcare.

How many employees does Scorpion Therapeutics have?

Scorpion Therapeutics has 51-200 employees.

Scorpion Therapeutics

Boston, United States · Founded 2020 · $420.0M raised

Biotech

Healthcare

Headquarters: Boston, Massachusetts
Employees: 51–200
Founded: 2020
Business Model: B2B

Website: scorpiontx.com
Total Funding: $420.0M
Last Round: $150.0M Series CJul 2024
Rounds: 3

About

Scorpion Therapeutics is a clinical-stage precision oncology company developing transformational targeted therapies for patients with cancer. Founded in 2020, the company built a proprietary technology platform to identify and drug cancer-driving mutations. Its lead program STX-478, a mutant-selective PI3Kα inhibitor, was acquired by Eli Lilly in early 2025.

Summary

Scorpion Therapeutics is a Biotech company based in Boston, United States, founded in 2020. It has raised $420.0M in total across 3 rounds, most recently a $150.0M Series C round in Jul 2024. Investors include Atlas Venture, Vida Ventures and Frazier Life Sciences.

LinkedIn X (Twitter)